Therapy for acute heart failure syndromes
- PMID: 19379639
- DOI: 10.1007/s11886-009-0028-6
Therapy for acute heart failure syndromes
Abstract
The pharmacologic management of acute heart failure syndromes (AHFS) has changed little over the past 15 years. Traditional therapies, such as nitrates and loop diuretics, remain the mainstay of therapy, with inotropes reserved for patients who present in shock or an advanced low-output state. We review the use of these therapies in AHFS with added insights from recent clinical trials and registry data.
Similar articles
-
Outpatient parenteral inotropic therapy for advanced heart failure.J Heart Lung Transplant. 2000 Aug;19(8 Suppl):S49-57. doi: 10.1016/s1053-2498(99)00107-2. J Heart Lung Transplant. 2000. PMID: 11016488 Review.
-
Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.Am J Cardiol. 2006 Dec 15;98(12):1627-30. doi: 10.1016/j.amjcard.2006.07.044. Epub 2006 Oct 25. Am J Cardiol. 2006. PMID: 17145223
-
Pharmacotherapy for acute heart failure syndromes.Am J Health Syst Pharm. 2011 Jan 1;68(1):21-35. doi: 10.2146/ajhp100202. Am J Health Syst Pharm. 2011. PMID: 21164062 Review.
-
Review of current and investigational pharmacologic agents for acute heart failure syndromes.Am J Cardiol. 2007 Jan 22;99(2A):4A-23A. doi: 10.1016/j.amjcard.2006.11.025. Epub 2006 Nov 27. Am J Cardiol. 2007. PMID: 17239703 Review.
-
Long-term intravenous inotropes in low-output terminal heart failure?Clin Res Cardiol. 2016 Jun;105(6):471-81. doi: 10.1007/s00392-016-0968-y. Epub 2016 Feb 15. Clin Res Cardiol. 2016. PMID: 26879807 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous